Articles and posts USelectAllNewsPresentationsArticlesNeola Medical Q3 report 2022 – Important milestone reached as clinical study on 100 newborn babies was finalizedNovember 10, 2022 | News, RegulatoryInvitation to Neola Medical’s presentation of the Q3-report 2022November 9, 2022 | News, Non regulatoryNeola Medical presents at BioStock Life Science Fall Summit 2022November 4, 2022 | NewsNeola Medical invites to presentation of the Q3-report 2022November 3, 2022 | News, Non regulatoryNeola Medical carries out a directed issue of shares to guarantors in connection with rights issueOctober 28, 2022 | News, Non regulatoryBorn preterm – a fight for lifeOctober 27, 2022 | Articles, NewsCEO Hanna Sjöström in the podcast A Little Light Listening – Light Saving LungsOctober 25, 2022 | NewsNeola Medical announces outcome of rights issueOctober 20, 2022 | News, Non regulatoryNeola Medical’s Clinical Manager, Ph.D. MD Tetiana Kovtiukh, at the EAPS 2022 in BarcelonaOctober 18, 2022 | NewsNeola Medical inleder biologisk utvärdering och tester inför marknadsgodkännande – erhåller anslag från VinnovaOctober 17, 2022 | News, Non regulatoryCEO Hanna Sjöström presenting the company in Aktieportföljen LiveOctober 14, 2022 | News, PresentationsNeola Medical’s new trademark has been registered in the European UnionOctober 13, 2022 | News, Non regulatory# 12345678910111213141516171819202122232425262728 $ For InvestorsWe are on a journey to revolutionize neonatal intensive careLearn more about investing in Neola Medical Join our journey
Neola Medical Q3 report 2022 – Important milestone reached as clinical study on 100 newborn babies was finalizedNovember 10, 2022 | News, Regulatory
Invitation to Neola Medical’s presentation of the Q3-report 2022November 9, 2022 | News, Non regulatory
Neola Medical carries out a directed issue of shares to guarantors in connection with rights issueOctober 28, 2022 | News, Non regulatory
CEO Hanna Sjöström in the podcast A Little Light Listening – Light Saving LungsOctober 25, 2022 | News
Neola Medical’s Clinical Manager, Ph.D. MD Tetiana Kovtiukh, at the EAPS 2022 in BarcelonaOctober 18, 2022 | News
Neola Medical inleder biologisk utvärdering och tester inför marknadsgodkännande – erhåller anslag från VinnovaOctober 17, 2022 | News, Non regulatory
CEO Hanna Sjöström presenting the company in Aktieportföljen LiveOctober 14, 2022 | News, Presentations
Neola Medical’s new trademark has been registered in the European UnionOctober 13, 2022 | News, Non regulatory